Home » Topics » BioWorld Science

BioWorld Science
RSS

Signal acquires rights to novel signaling proteins

Dec. 11, 1996

EntreMed in-licenses angiogenesis inhibitor

Dec. 11, 1996

Warfarin underused for stroke prevention

Dec. 11, 1996

Medarex to acquire Houston Biotechnology

Dec. 11, 1996

DepoTech files IND for DepoMorphine

Dec. 11, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

Antithrombin III advances to phase II

Dec. 11, 1996

Alliance Pharmaceutical: Annual Report 1996

Dec. 11, 1996

Allelix reports thrombospondin-derived antihemorrhagic peptide

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...